P. Rose

发表

Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies

F. Peyvandi, R. Liesner, B. Hunt, 2012, British journal of haematology.

Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics

T. Nokes, P. Rose, R. Arya, 2009, Thrombosis and Haemostasis.

More on thromboprophylaxis: quantifying risk for venous thromboembolism.

T. Nokes, N. Parsons, P. Rose, 2009, Thrombosis and haemostasis.

Elevated D-dimers are also a marker of underlying malignancy and increased mortality in the absence of venous thromboembolism

P. Rose, S. Paneesha, A. McManus, 2010, Journal of Clinical Pathology.

High D‐dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes

P. Rose, S. Paneesha, E. Cheyne, 2006, British journal of haematology.

Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias

B. Hunt, S. Machin, P. Rose, 2003, British journal of haematology.

The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome

T. C. Roy, D. Milford, B. Rowe, 2004, Pediatric Nephrology.

Derivation and Validation of a Prediction Tool for Venous Thromboembolism: A VERITY Registry Study.

T. Nokes, N. Parsons, P. Rose, 2007 .

Impact of venous thromboembolism on survival in patients with malignancy

T. Nokes, P. Rose, R. Arya, 2009, British journal of haematology.

Susceptibility of AML cells to in vitro apoptosis correlates with heat shock protein 70 (hsp70) expression

P. Rose, A. Morris, I. Chant, 1996, British journal of haematology.

The treatment of chronic idiopathic thrombocytopenia with anti-D (Rho) immunoglobulin: its effectiveness, safety and mechanism of action.

T. Baglin, P. Rose, R. Chakraverty, 1988, Clinical and laboratory haematology.

Multiple cutaneous plasmacytomas following an autologous peripheral stem cell transplant

P. Rose, R. Charles-Holmes, J. Marsden, 2002, Clinical and experimental dermatology.

Plasmacytoma relapses in the absence of systemic progression post‐high‐dose therapy for multiple myeloma

K. Rezvani, S. Basu, E. Terpos, 2005, European Journal of Haematology.

Thrombosis and cancer

C. Poole, A. Kakkar, P. Rose, 2004, Nature Reviews Clinical Oncology.

Risk Factors for Venous Thromboembolism

P. Rose, 2017 .

Evaluating the Performance of a Previously Reported Risk Score To Predict Venous Thromboembolism: A VERITY Registry Study.

T. Nokes, P. Rose, R. Arya, 2006 .

Risk factors for cancer‐associated venous thromboembolism in outpatient deep venous thrombosis clinics

T. Nokes, P. Rose, R. Arya, 2010, British journal of haematology.

High D-dimer level at presentation in patients with venous thrombosis is a marker for malignancy.

J. Delgado, P. Rose, S. Paneesha, 2005, Haematologica.

Venous thromboembolism registry: a route to improved patient outcomes.

P. Rose, N. Scriven, Daniel D. Cummins, 2004, Hospital medicine.